Novartis's market cap is currently $250.07B. The company's EPS TTM is $2.42; its P/E ratio is 18.94; and it has a dividend yield of 3.06%. Novartis is scheduled to report earnings on July 17, 2025, and the estimated EPS forecast is $2.29. See an overview of income statement, balance sheet, and cash flow financials.
